Literature DB >> 3132367

Evidence of immunoregulation of the composition of intestinal microflora and its practical consequences.

D van der Waaij1.   

Abstract

Mesh：

Year:  1988        PMID： 3132367     DOI： 10.1007/bf01962193

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN： 0934-9723            Impact factor:   3.267


× No keyword cloud information.
  23 in total

1.  Effect of a lactobacillus product administration on the anaerobic intestinal flora of aged adults.

Authors:  T Yamagishi; T Serikawa; R Morita; K Takahashi; S Nishida
Journal:  Jpn J Microbiol       Date:  1974-05

2.  Inhibition of specific immune responses by feeding protein antigens. II. Effects of prior passive and active immunization.

Authors:  D G Hanson; N M Vaz; L A Rawlings; J M Lynch
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

3.  The relation between diet and the gut microflora in man.

Authors:  B S Drasar; J S Crowther; P Goddard; G Hawksworth; M J Hill; S Peach; R E Williams; A Renwick
Journal:  Proc Nutr Soc       Date:  1973-09       Impact factor: 6.297

Review 4.  Studies on gastrointestinal mucus.

Authors:  A Allen; W J Cunliffe; J P Pearson; L A Sellers; R Ward
Journal:  Scand J Gastroenterol Suppl       Date:  1984

Review 5.  The digestive tract in immunocompromised patients: importance of maintaining its resistance to colonization, especially in hospital in-patients and those taking antibiotics.

Authors:  D van der Waaij
Journal:  Antonie Van Leeuwenhoek       Date:  1984       Impact factor: 2.271

6.  Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract.

Authors:  D T Sleijfer; N H Mulder; H G de Vries-Hospers; V Fidler; H O Nieweg; D van der Waaij; H K van Saene
Journal:  Eur J Cancer       Date:  1980-06       Impact factor: 9.162

7.  Effects of antigen-feeding on intestinal and systemic immune responses. II. Suppression of delayed-type hypersensitivity reactions.

Authors:  M F Kagnoff
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

8.  Prevention of infection by trimethoprim-sulfamethoxazole plus amphotericin B in patients with acute nonlymphocytic leukaemia.

Authors:  A W Dekker; M Rozenberg-Arska; J J Sixma; J Verhoef
Journal:  Ann Intern Med       Date:  1981-11       Impact factor: 25.391

9.  Variations in the anaerobic faecal flora of ten healthy human volunteers with special reference to the Bacteroides fragilis-group and Clostridium difficile.

Authors:  G J Meijer-Severs; E van Santen
Journal:  Zentralbl Bakteriol Mikrobiol Hyg A       Date:  1986-02

10.  Systemic tolerance and secretory immunity after oral immunization.

Authors:  S J Challacombe; T B Tomasi
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307
View more
  5 in total

1.  Clinical use of selective decontamination: the concept.

Authors:  D van der Waaij; W L Manson; J P Arends; H G de Vries-Hospers
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

2.  Micromorphometrical analysis of rodent related (SPF) and unrelated (human) gut microbial flora in germfree mice by digital image processing.

Authors:  D Veenendaal; J de Boer; B C Meijer; D van der Waaij; M H Wilkinson
Journal:  Epidemiol Infect       Date:  1996-02       Impact factor: 2.451

3.  The colonization resistance of the digestive tract in different animal species and in man; a comparative study.

Authors:  D Van der Waaij; B D Van der Waaij
Journal:  Epidemiol Infect       Date:  1990-10       Impact factor: 2.451

4.  The correlation between Clostridium-difficile infection and human gut concentrations of Bacteroidetes phylum and clostridial species.

Authors:  E Goldberg; I Amir; M Zafran; U Gophna; Z Samra; S Pitlik; J Bishara
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-19       Impact factor: 3.267

5.  Nondigestible oligosaccharides enhance bacterial colonization resistance against Clostridium difficile in vitro.

Authors:  Mark J Hopkins; George T Macfarlane
Journal:  Appl Environ Microbiol       Date:  2003-04       Impact factor: 4.792
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.